Human Milk for Congenital Gastrointestinal Disorders

NACompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

July 26, 2018

Primary Completion Date

January 18, 2022

Study Completion Date

January 18, 2022

Conditions
Congenital Gastrointestinal Disorders
Interventions
OTHER

Human Milk

Participants will receive an exclusive human milk diet comprised of mother's own milk (MOM, pasteurized donor human milk (DM) fortified with a donor-milk based fortifier (DMBF): Prolact+ for infants \<37 weeks PMA and/or or weight \<2,200g or PBCLN-002 for infants \>37 weeks PMA and/or weight \>2,200g)

Trial Locations (1)

30322

Children's Healthcare of Atlanta-Egleston, Atlanta

All Listed Sponsors
collaborator

Chatham Valley Foundation

UNKNOWN

collaborator

Prolacta Bioscience

INDUSTRY

lead

Emory University

OTHER

NCT02567292 - Human Milk for Congenital Gastrointestinal Disorders | Biotech Hunter | Biotech Hunter